Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
4-maximum elevation of of the tail
Understanding concentrations Empower offers two concentrations for the injection: 8 mg/mL and 17 mg/mL
Its Phase 2/3 LIFT-AD Alzheimer's trial failed its primary endpoint, announced September 3, 2024 (global statistical test 0.08, P = .70)
The observed linearity helped assess the models internal consistency
No pharmacokinetic or pharmacodynamic interaction studies exist for the combination
getProductCode(psProduct) psProduct } priceList[psProduct } priceList[psProduct } priceList[psProduct } Login Product removed from your favourites message message message message addToCartData }
US$ 27.47
US$ 20.16
US$ 21.37
US$ 23.54
US$ 25.66
US$ 27.97
US$ 21.92
US$ 29.86
